SAIA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Based on the data provided, Saia Inc (SAIA) is not a strong buy for a beginner, long-term investor at this moment. While the stock has bullish moving averages and hedge funds are increasing their positions, the company's financial performance in the latest quarter shows significant declines in net income and EPS. Additionally, insider selling has surged, and the options data indicates a bearish sentiment with a high Open Interest Put-Call Ratio of 1.75. Analyst ratings are mixed, with some downgrades and concerns about elevated costs. Given these factors, it is recommended to hold off on buying SAIA for now and monitor for stronger positive catalysts or improved financial performance.
The technical indicators for SAIA show mixed signals. The MACD is below 0 (-0.802) and negatively contracting, indicating bearish momentum. The RSI is neutral at 58.478, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its pivot level of 388.468, with resistance at 410.135 and support at 366.801.
Hedge funds are significantly increasing their positions, with a 1241.86% increase in buying over the last quarter. Analysts have raised price targets, with some seeing potential upside as the freight cycle recovers. The appointment of a tech-savvy executive to the board could enhance operational efficiency.
Insider selling has surged by 1875.02% in the last month, indicating potential lack of confidence from insiders. Financial performance in Q4 2025 showed a -37.56% drop in net income and a -37.46% drop in EPS YoY. Elevated costs remain a concern, and some analysts have downgraded the stock, citing risks and balanced risk-reward scenarios.
In Q4 2025, Saia's revenue increased slightly by 0.13% YoY to $789.95M. However, net income dropped significantly by -37.56% YoY to $47.52M, and EPS fell by -37.46% YoY to $1.77. Gross margin also declined by -2.91% YoY to 64.39%.
Analyst ratings are mixed. While several analysts raised price targets (e.g., UBS to $493, Stephens to $445), others downgraded the stock (e.g., Morgan Stanley to Underweight with a $250 target). Concerns about elevated costs and lack of evidence for meaningful EPS growth weigh on the stock's outlook.
